Pfizer and AbbVie oral migraine drugs earn top spots with physicians, survey finds
Oral drugs have raced to the front of the pack in the crowded migraine therapy space and appear to be staying put with physicians. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
